Avita Medical, Inc. Common Stock vs. Stryker Corporation
Stryker Corporation (SYK) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| RCEL | SYK | |
|---|---|---|
| Market Cap | $347.00 million | $105.17 billion |
| Revenue (TTM) | $75.63 million | $25.84 billion |
| Net Income (TTM) | $-43,082,000 | $3.73 billion |
SYK leads on 3 of 3 size & scale factors.
Valuation
| RCEL | SYK | |
|---|---|---|
| P/E Ratio | — | 28.64 |
| Price / Book | -12.46 | 4.38 |
| Price / Sales | 4.59 | 4.07 |
RCEL and SYK split the valuation factors evenly.
Profitability
| RCEL | SYK | |
|---|---|---|
| Net Margin | -56.96% | 14.43% |
| Return on Equity | 154.76% | 15.55% |
RCEL and SYK split the profitability factors evenly.
Dividend
| RCEL | SYK | |
|---|---|---|
| Dividend Yield | — | 1.27% |
| Payout Ratio | — | 36.48 |
RCEL and SYK split the dividend factors evenly.
Risk & Sentiment
| RCEL | SYK | |
|---|---|---|
| Short Interest | 0.34% | 1.53% |
RCEL leads on 1 of 1 risk & sentiment factors.
Dig deeper: RCEL overview, RCEL financials, SYK overview, SYK financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.